Clinical Trials
- Comparison of 3 Methods to Diagnose Endolymphatic Hydrops in Meniere’s Disease
- Effects of Infrasound Exposure on Measures of Endolymphatic Hydrops
- Ménière’s Disease Registry
- Prevalence of Endolymphatic Hydrops in Patients With a History of Congenital Cytomegalovirus Infection With Symptomatic Cochleo-vestibular Involvement
- Refractory Eustachian Tube Dysfunction: Are the Symptoms Related to Endolymphatic Hydrops
- 36-Month Post-marketing Surveillance and Analysis of Menactra Vaccine in 2-10 Year Olds
- Assessment of Antibody Persistence at Eighteen Months After the Completion of the Vaccination Course in Study V72P10
- Dose-finding and Safety of 2 Intradermal MEN-ACYW135-conjugate Vaccines
- Evaluating the Comparative Safety and Immunogenicity of Three Lots of Novartis Meningococcal C Conjugate Vaccine in Healthy Toddlers
- Evaluation of Meningococcal ACWY Immune Response in Children Aged 40 and 60 Months
- Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Infant Study
- Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
- Post-Marketing Safety Study of Menactra® in Healthy Children, Adolescents, and Adults in the Philippines
- Propositive (Protecting Positive People From Meningococcal Infection) Follow-up Study
- Safety and Immunogenicity of Meningococcal ACWY Conjugate Versus Polysaccharide Vaccine in Children 2 to 10 Years of Age
- Safety of MenACWY-CRM Vaccination in Adolescents
- Safety Surveillance of MenACWY-CRM Vaccine in Children
- Safety, Tolerability and Immunogenicity of Three Doses of Novartis Meningococcal B Vaccine When Administered to Healthy At-risk Adults
- Safety, Tolerability and Immunogenicity of Two Different Formulations of Meningococcal B Recombinant Vaccine, When Administered to Healthy Infants
- Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
- Study of the Safety and Immune Response of Two Serogroup B Meningococcal Vaccines Administered to Healthy Adolescents
- Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine
- An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in the mRNA-3705-P101 Study
- Combined Malonic and Methylmalonic Aciduria (CMAMMA): Gene Identification and Outcome Study
- Long-term Follow-up Study of Patients Who Received hLB-001 Gene Therapy